BSN Capital Partners’s Ecolab ECL Stock Holding History

BSN Capital Partners’s Portfolio ECL Stock Details ECL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-73,520	Closed	-$20.1M	–	22
2026 Q2	$20.1M	Buy	+73,520	New	+$19.4M	0.91%	24
2024 Q4	–	Sell	-67,900	Closed	-$16.4M	–	24
2024 Q3	$16.4M	Buy	+67,900	New	+$16.6M	3.2%	11

Other funds holding ECL

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return

BSN Capital Partners's ECL Position: Q3 2026 in Review

BSN Capital Partners sold out of Ecolab (ECL) in Q3 2026, closing a stake of 73,520 shares — an estimated $20.1M sold.

BSN Capital Partners first reported a position in ECL in Q3 2024 and held it in 2 quarters. The position peaked at $20.1M in Q2 2026. 1,454 funds tracked by Wall St. Rank hold ECL as of Q3 2026.

BSN Capital Partners reported no remaining Ecolab position as of Q3 2026 after selling out during the quarter.
BSN Capital Partners sold 73,520 Ecolab shares in Q3 2026, an estimated $20.1M.
BSN Capital Partners first reported a position in Ecolab in Q3 2024 and held it in 2 quarters.
BSN Capital Partners's Ecolab position peaked at $20.1M in Q2 2026.
1,454 funds tracked by Wall St. Rank held Ecolab as of Q3 2026.

Based on BSN Capital Partners's 13F filing for Q3 2026, filed 23 Oct 2026.